Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale-Reference-Cited by-同舟云学术

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale

Published:2017-11 Issue:11 Volume:48 Page:3073-3077
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Merkler Alexander E.¹,Gialdini Gino¹,Yaghi Shadi¹,Okin Peter M.¹,Iadecola Costantino¹,Navi Babak B.¹,Kamel Hooman¹

Affiliation:

1. From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute (A.E.M., G.G., C.I., B.B.N., H.K.), Department of Neurology (A.E.M., C.I., B.B.N., H.K.), and Division of Cardiology (P.M.O.), Weill Cornell Medicine, New York; and Department of Neurology, the Warren Alpert Medical School of Brown University, Providence, RI (S.Y.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference33 articles.

1. Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both

2. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study

3. Long-Term Experience and Outcomes With Transcatheter Closure of Patent Foramen Ovale

4. Long-term follow-up after PFO device closure

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Approach to Patent Foramen Ovale Closure for Cryptogenic Stroke;Neurology Clinical Practice;2024-08

2. Stroke;The Lancet;2024-06

3. Feasibility and safety of cryoballoon ablation for atrial fibrillation and closing patent foramen ovale without implantation：A pilot study;Heart Rhythm;2024-06

4. Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale;Journal of Stroke;2024-05-31

5. Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-12